Abstract

P1.01-113 Analysis of Clinicopathological Features and Clinical Efficacy of Crizotinib in ROS1 Positive Non-Small Cell Lung Cancer

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
ROS1 Positive Non-Small Cell Lung Cancer Patient with Brain Metastases Who Overcame Crizotinib Resistance with Lorlatinib: Case Report
Soukaina Bekkouche ... El Ghissassi Ibrahim
SAS Journal of Medicine | VOL. 10
Soukaina Bekkouche, et. al.Soukaina Bekkouche ... El Ghissassi Ibrahim
01 Mar 2024
Phase II study of brigatinib in ROS1 positive non-small cell lung cancer (NSCLC) patients previously treated with crizotinib: Barossa cohort 2.
Haruko Daga ... Shogo Nomura
Journal of Clinical Oncology | VOL. 39
Haruko Daga, et. al.Haruko Daga ... Shogo Nomura
20 May 2021
Clinicopathologic, genomic and protein expression characterization of 356 ROS1 fusion driven solid tumors cases.
Richard S P Huang ... James Haberberger
Radiation oncology investigations | VOL. 148
Richard S P Huang, et. al.Richard S P Huang ... James Haberberger
23 Dec 2020
Taletrectinib for the treatment of ROS-1 positive non-small cell lung cancer: a drug evaluation of phase I and II data
Misako Nagasaka ... Sai-Hong Ignatius Ou
Expert Opinion on Investigational Drugs | VOL. 33
Misako Nagasaka, et. al.Misako Nagasaka ... Sai-Hong Ignatius Ou
29 Jan 2024
View more papers

More From: Journal of Thoracic Oncology

Paper Title
Journal
Date
Author
From the IASLC Early Detection and Screening Committee Terminology Issues in Screening and Early Detection of Lung Cancer – IASLC Early Detection and Screening Committee Expert Group Recommendations
Rudolf M Huber ... Rudolf Huber
Journal of Thoracic Oncology | VOL. -
Rudolf M Huber, et. al.Rudolf M Huber ... Rudolf Huber
02 Aug 2024
Lung-MAP Next Generation Sequencing Analysis of Advanced Squamous Cell Lung Cancers (SWOG S1400)
David Kozono ... Mary W Redman
Journal of Thoracic Oncology | VOL. -
David Kozono, et. al.David Kozono ... Mary W Redman
01 Aug 2024
Real-World Acute Toxicity and 90-Day Mortality in Patients With Stage I NSCLC Treated With Stereotactic Body Radiotherapy
Peter S.N Van Rossum ... José S.A Belderbos
Journal of Thoracic Oncology | VOL. -
Peter S.N Van Rossum, et. al.Peter S.N Van Rossum ... José S.A Belderbos
25 Jul 2024
Analysis of Circulating Tumor DNA Predicts Outcomes of Short-Course Consolidation Immunotherapy in Unresectable Stage III NSCLC
Soyeong Jun ... Maximilian Diehn
Journal of Thoracic Oncology | VOL. -
Soyeong Jun, et. al.Soyeong Jun ... Maximilian Diehn
05 Jul 2024
View more papers